Hemolink modified hemoglobin red blood cell substitute: Phase II Update

Hemosol Inc. (TSE:HML), Toronto, Ontario
Product: Hemolink modified hemoglobin

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE